Holger Schirutschke - Concepedia

Author

Holger Schirutschke

University Hospital Carl Gustav Carus ORCID

Also Known As

H Schirutschke, H. Schirutschke, Holger Schirutschke, Schirutschke, Holger

Publications

522

Citations

H-Index

Concepts

All Affiliations

University Hospital Carl Gustav Carus Klinik und Poliklinik für Psychotherapie und Psychosomatik Technische Universität Dresden Vogtland-Klinik National Center for Tumor Diseases

About

Holger Schirutschke is an author at University Hospital Carl Gustav Carus specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	102
2	Health Sciences	2	2	28
3	Cell Biology	2	2	28
4	Engineering	1	1	33
5	Biomedical Engineering	1	1	33

Holger Schirutschke

Publications

496

Citations

H-Index

Page 1

	Year	Citations
Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine Julian Stumpf, Torsten Siepmann, Tom H. Lindner, The Lancet Regional Health - Europe	2021	304
The Graft Content of Donor T Cells Expressing γδTCR+ and CD4+foxp3+ Predicts the Risk of Acute Graft versus Host Disease after Transplantation of Allogeneic Peripheral Blood Stem Cells from Unrelated Donors Caroline Pabst, Holger Schirutschke, Gerhard Ehninger, Clinical Cancer Research	2007	90
Influence of peritoneal dialysis solution on measurements of fluid status by bioimpedance spectroscopy Simon Parmentier, Holger Schirutschke, Bertram Schmitt, International Urology and Nephrology HemodialysisRenal FunctionEngineeringBioimpedance SensorsFluid Status	2012	33
Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc study Julian Stumpf, Jörg Schwöbel, Tom H. Lindner, The Lancet Regional Health - Europe VaccinationObservational Dia-vacc StudyVaccine DevelopmentTransplant PatientsImmunology	2022	29
Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation Astrid Schulze, Holger Schirutschke, Uta Oelschlägel, Experimental Hematology Cell TherapyTransplantationMarrow TransplantationMedicineStem Cell Transplantation	2008	17
Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers? Holger Schirutschke, Alexander Paliege Nephrology Dialysis Transplantation GlomerulonephritisUrologyRenal FunctionVasopressin V2 AntagonistKidney Failure	2018	12
Injured kidney endothelium is only marginally repopulated by cells of extrarenal origin Holger Schirutschke, Regina Vogelbacher, Andrea Stief, American Journal of Physiology-Renal Physiology Renal PathologyImmunologyRat Kidney GraftsRat ModelsTissue Transplantation	2013	11

Page 1